News
Feed
Events
Feed
News
+ Events
Feed

NascaCell Technologies AG

  • ISIN DE000A0F5WL9
  • Country Deutschland

Latest News

9 September 2010

15:40 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG: Ausschüttung des Liquidationsüberschuss / Einstellung Handel der Aktien

30 January 2009

13:50 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG: Außerordentliche Hauptversammlung zur Beschlussfassung einer Liquidation

18 December 2008

13:42 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG: Außerordentliche Hauptversammlung zur Beschlussfassung einer Liquidation

3 December 2008

10:26 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG:Börse München widerruft Notiz der NascaCell-Aktie im M:access

5 June 2008

14:37 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG: Verlustanzeige nach § 92 Abs. 1 AktG

12 February 2008

09:30 Corporate

NascaCell Technologies AG

Corporate

Archemix and NascaCell expand strategic alliance for aptamer-based drug discovery

30 January 2008

10:29 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG gibt Veränderungen im Vorstand bekannt

18 October 2007

08:34 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG and the University of Massachusetts develop Aptamers and Microbodies™ against Botulinum toxin (Botox)

11 October 2007

08:32 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG and Boehringer Ingelheim sign collaboration agreement on therapeutic Microbodies™

31 July 2007

09:11 Corporate

NascaCell Technologies AG

Corporate

Eurogentec and NascaCell Technologies AG sign marketing agreement

17 July 2007

09:16 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG receives additional funding from the BioChance Plus program

18 April 2007

15:46 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG increased revenues in 2006 by 50 %

3 April 2007

09:29 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG receives US Patent to generate Microbodies

13 March 2007

09:46 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG receives funding from EUROTRANS-BIO for the development of lab-on-a-chip systems for aptamer development and multiplex analysis of biomolecular interactions

5 December 2006

16:57 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG schließt Barkapitalerhöhung ab – 600.000 Aktien platziert

9 November 2006

17:13 Corporate DE

NascaCell Technologies AG

Corporate
DE

Wertpapierprospekt der NascaCell Technologies AG gebilligt – Barkapitalerhöhung und Handelsaufnahme der Aktie im M:access der Börse München geplant

12 September 2006

09:08 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG kooperiert mit AstraZeneca

22 June 2006

08:41 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG: Kapitalerhöhung erfolgreich platziert

12 June 2006

11:20 Corporate DE

NascaCell Technologies AG

Corporate
DE

NascaCell Technologies AG schließt Kooperationsvertrag mit der Technischen Universität Darmstadt

1 June 2006

08:30 Corporate

NascaCell Technologies AG

Corporate

NascaCell Technologies AG: NascaCell Technologies AG signed a cooperation agreement with Bayer CropScience

Upcoming Events

No Events found